The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) — ADAM L. BOXER (UNIVERSITY OF CALIFORNIA, SAN FRANCISCO)
PROJECT SUMMARY / ABSTRACT Progressive Supranuclear Palsy (PSP) is a severe neurodegenerative disease of aging that usually leads to death within 5-7 years of diagnosis. There are no effective treatme
| Project title | The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) |
|---|---|
| Project number | 1R01AG085029-01 |
| PI name | ADAM L. BOXER |
| Institution | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
| Funding mechanism | R01 |
| Agency | NIA |
| Award amount | $15.78M |
| Fiscal year | 2024 |
| Project start | 2024-08-15T00:00:00 |
| Project end | 2029-07-31T00:00:00 |
| Abstract | PROJECT SUMMARY / ABSTRACT Progressive Supranuclear Palsy (PSP) is a severe neurodegenerative disease of aging that usually leads to death within 5-7 years of diagnosis. There are no effective treatme |
| Key terms | <AD dementia><Accounting><Activities of Daily Living><Activities of everyday life><Alzheimer Type De |
$799/mo
Try GrantRadar →